Application YC di Uncommon Therapeutics

Winter 2025Active

Uncommon Therapeutics ha partecipato a Y Combinator nel batch Winter 2025 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2025
Settore: HealthcareTherapeutics
Dimensione team: 2
Stato: Active
Lanciata: 2025

Founder

Noah AuerhahnFounder
Ryan LimFounder

Cosa fa Uncommon Therapeutics

Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.

Application YC di Uncommon Therapeutics, ricostruita

Domanda per Y Combinator

Uncommon Therapeutics, batch Winter 2025. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Uncommon Therapeutics

Describe what your company does in 50 characters or less.

A Disease Focused Biotech, Building Multiple Billion Dollar Drugs

What is your company going to make? Please describe your product and what it does or will do.

We design gene therapies using a polytherapy approach to treat rare genetic diseases like Rett Syndrome. Our treatments improve patients' quality of life and aim to deliver cures by addressing multiple disease mechanisms.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, CA, and the company would remain based here after YC.

Explain your decision regarding location.

San Francisco has the biotech ecosystem and talent we need. We're already here full-time and close to the patients and partners we work with.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Uncommon Therapeutics?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Uncommon Therapeutics (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Uncommon Therapeutics si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Uncommon Therapeutics?

Uncommon Therapeutics apparteneva al batch Winter 2025 di Y Combinator.

Chi ha fondato Uncommon Therapeutics?

Uncommon Therapeutics è stato fondato da Noah Auerhahn, Ryan Lim.

Cosa fa Uncommon Therapeutics?

A Disease Focused Biotech, Building Multiple Billion Dollar Drugs

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Uncommon Therapeutics, e di ogni altro batch YC, è in YC Insights.